顾昕

昕 顾 is currently the Executive Director and Head of CMC at IGNIS Therapeutics, a position they have held since 2025. Prior to this, they served as Senior Director, Head of CMC at 翼思生物医药 from 2021 to 2025 and Associate Director of CMC project management at BeiGene from 2019 to 2021. 昕 also briefly worked as Engineering Head and MS&T Head at the Suzhou Site of 诺华 in 2019. They are pursuing a Ph.D. in Organic Chemistry at 中国科学院上海有机化学研究所.